You're browsing HLTH 2018's website. Visit to explore this year's edition!

Main caricature of Kelly J. Clark, MD, MBA, DFAPA, DFASAM, who is speaking at HLTH and is President at American Society of Addiction Medicine Overlay caricature of Kelly J. Clark, MD, MBA, DFAPA, DFASAM, who is speaking at HLTH and is President at American Society of Addiction Medicine

Kelly J. Clark, MD, MBA, DFAPA, DFASAM


American Society of Addiction Medicine

Board certified in both addiction medicine and psychiatry, Dr. Kelly Clark has focused her career on issues of addictive disease, evidence informed behavioral health care, and payment reform. She is Chief Medical Officer of CleanSlate Centers, a multi-state medical group currently treating over 6,000 opioid addicted patients with medication and psychosocial care. CleanSlate has received a SAMHSA Science to Service Award for Office Based Opioid Treatment and a Center of Excellence Award from the Commonwealth of Pennsylvania. She is active on the Association of Managed Care Pharmacy’s Addiction Treatment Advisory Group; a member of the American Psychiatric Associations Integration Work Group; served on the writing committee of the Johns Hopkins Bloomberg School of Public Health’s recent policy document, “The Prescription Drug Epidemic: An Evidence Based Approach”; has serves as expert to the National Safety Council and the United States Comptroller General; has been a member of the Collaborative Care Research Network Steering Committee of the American Academy of Family Practice; and led the workgroup on Health Systems and Reimbursement at SAMHSA’s Buprenorphine Summit. She continues her work as a founding member of the Advisory Board of the National Rx Drug Abuse and Heroin Summit.

Dr. Clark’s expertise in health care delivery systems and financing is built upon her vast breadth of clinical work including emergency, acute, sub-acute, and chronic institutions; community, county, state, federal sites; tax-paying and non-profit care systems; voluntary, involuntary and penal settings. She also has consulted in a variety of capacities including in expert review for utilization, disability, worker’s compensation, and pharmacy benefit management organizations; for pharmaceutical companies; and as an independent psychiatric expert to the courts in Kentucky and Rhode Island as well as the United States Social Security Administration. Clark has also been Chief Medical Officer for Behavioral Health Group, with over 28 opioid treatment programs in 8 states during her tenure. As Behavioral Health Medical Director of Capitol District Physician’s Health Plan, she provided the clinical leadership for in-sourcing the management of behavioral health benefits, improving the quality and value of care received by members by integrating physical and behavioral health teams. As Medical Director at CVS Caremark, Clark addressed issues such as the overutilization of opioids and benzodiazepines.

Dr. Clark earned an MBA from The Fuqua School of Business at Duke University, Durham, NC; her medical degree from University of Wisconsin, Madison, WI; and a bachelor degree in psychology from Coe College, Cedar Rapids, IA. She completed residency in psychiatry at the Medical College of Wisconsin. With expertise in payment models, quality metrics, medical-behavioral health integration, and clinical care delivery systems, as well as a wealth of clinical experience treating people with addictive disease, Dr. Clark currently focuses on the epidemic of opioid addiction.